Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Evolent Health, Inc Class A Common Stock (NY:EVH)

4.710 +0.130 (+2.84%)
Official Closing Price Updated: 4:10 PM EST, Nov 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Evolent Health, Inc Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
News headline image
What Evolent Health (EVH) Said on Its Q3 Earnings Call ↗
Via MarketBeat
News headline image
EVH Q3 2026 deep dive: ongoing AI investment and customer expansion shape outlook
Healthcare solutions company Evolent Health (NYSE:EVH) met Wall Street’s revenue expectations in Q3 2026, with sales up 51.3% year on year to $725.4 million.... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health (EVH) Q3 2026 Earnings Call Transcript ↗
Oncology and AI-driven efficiencies anchor the quarter's stronger profit picture. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
Evolent Health (NYSE:EVH) Q3 2026 Earnings: In-Line Revenue, EPS Beat, but Premarket Shares Slide ↗
Via Chartmill
Evolent Health (NYSE:EVH) Jumps 18% After Q2 Revenue and EPS Smash Estimates ↗
Via Chartmill
News headline image
GoodRx, Evolent Health, UFP Technologies, Centene, and HCA Healthcare shares skyrocket, what you need to know
What happened? A number of stocks jumped in the afternoon session after election results confirmed that Democrats reclaimed majorities in the House and Senat... 
Via StockStory
News headline image
Evolent Health earnings: what to look for from EVH
Healthcare solutions company Evolent Health (NYSE:EVH) will be announcing earnings results this Thursday before the bell. Here’s what investors should know. ... 
Via StockStory
News headline image
1 surging stock with competitive advantages and 2 that underwhelm
Great things are happening to the stocks in this article. They’re all outperforming the market over the last month because of positive catalysts such as a ne... 
Via StockStory
News headline image
1 unprofitable stock for long-term investors and 2 we avoid
Unprofitable companies face headwinds as they struggle to keep operating expenses under control. Some may be investing heavily, but the majority fail to conv... 
Via StockStory
News headline image
3 Value Stocks with Warning Signs
Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built the... 
Via StockStory
News headline image
1 Cash-Producing Stock to Target This Week and 2 Facing Headwinds
A company that generates cash isn’t automatically a winner. Some businesses stockpile cash but fail to reinvest wisely, limiting their ability to expand. Cas... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q2 Recap: Benchmarking Omnicell (NASDAQ:OMCL)
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking a... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q2 In Review: Astrana Health (NASDAQ:ASTH) Vs Peers
Wrapping up Q2 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) ... 
Via StockStory
News headline image
Q2 Earnings Highlights: Tandem Diabetes (NASDAQ:TNDM) Vs The Rest Of The Healthcare Technology Stocks
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at ... 
Via StockStory
News headline image
3 Reasons to Avoid EVH and 1 Stock to Buy Instead
The past six months have been a windfall for Evolent Health’s shareholders. The company’s stock price has jumped 48.6%, hitting $3.70 per share. This was par... 
Via StockStory
Topics Bankruptcy
News headline image
Q2 Healthcare Technology for Providers Earnings: Evolent Health (NYSE:EVH) Impresses
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Evolent Health (NYSE:... 
Via StockStory
News headline image
1 of Wall Street’s Favorite Stocks for Long-Term Investors and 2 We Find Risky
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
Healthcare Technology for Providers Stocks Q2 Teardown: Privia Health (NASDAQ:PRVA) Vs The Rest
Looking back on healthcare technology for providers stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including Privia Health (NASDAQ... 
Via StockStory
News headline image
1 Value Stock with Promising Prospects and 2 That Underwhelm
Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The ... 
Via StockStory
News headline image
Evolent Health (EVH) Q2 2026 Earnings Call Transcript ↗
Highmark launch drove 47% revenue growth; AI platform reached meaningful scale. 
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
5 Must-Read Analyst Questions From Evolent Health’s Q2 Earnings Call
Evolent Health’s second quarter results drew a significant positive market reaction, reflecting outperformance versus Wall Street’s expectations on both reve... 
Via StockStory
Topics Earnings
News headline image
1 Healthcare Stock Worth Your Attention and 2 We Brush Off
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have be... 
Via StockStory
News headline image
Reflecting On Healthcare Technology Stocks’ Q2 Earnings: GoodRx (NASDAQ:GDRX)
Earnings results often indicate what direction a company will take in the months ahead. With Q2 behind us, let’s have a look at GoodRx (NASDAQ:GDRX) and its ... 
Via StockStory
News headline image
3 Stocks Under $10 with Questionable Fundamentals
Stocks trading in the $1-10 range are generally smaller players with less risk than their penny stock counterparts. But that doesn’t mean the underlying busi... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health Q2 Earnings Call Highlights ↗
Evolent Health (NYSE:EVH) reported second-quarter revenue of $653 million, up 31% from the first quarter, and adjusted EBITDA of $28 million, up 27% sequentially, as the company benefited from the May... 
Via MarketBeat
Topics Earnings
News headline image
EVH Q2 2026 Deep Dive: Oncology Suite and AI Automation Drive Growth Amid Membership Headwinds
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea... 
Via StockStory
Topics Artificial Intelligence
News headline image
Evolent Health (NYSE:EVH) Reports Bullish Q2 CY2026, Stock Jumps 18.2%
Healthcare solutions company Evolent Health (NYSE:EVH) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 46.9% year on yea... 
Via StockStory
News headline image
Evolent Health Earnings: What To Look For From EVH
Healthcare solutions company Evolent Health (NYSE:EVH) will be reporting earnings this Thursday before market hours. Here’s what to look for. Evolent Health ... 
Via StockStory
News headline image
1 Small-Cap Stock for Long-Term Investors and 2 We Brush Off
Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that ... 
Via StockStory
News headline image
Why Evolent Health (EVH) Stock Is Nosediving
What Happened? Shares of healthcare solutions company Evolent Health (NYSE:EVH) fell 13% in the afternoon session after Wall Street firm Citi downgraded the ... 
Via StockStory
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.